4[2]Romain AP,Sonia AB,Peter MA,et al.Golbal strategy for the diagosis,management,and prevention of chronic ob-structive pulmonary disease[J].Am J Respir Crit Care Med,2003,167:1045～1049. 被引量：1
5[7]Hudson LD,et al.Efficacy of corticosteroids in patients with COPD,Med Clin North Am,1990,74:666～689. 被引量：1
6[8]Bonals SB,et al.Bone meneral density in women with asthma on long-term inhaled corticosteroid therapy[J].Ann Allergy Asthma Immunol,2000,85(6):495. 被引量：1
7[9]Nishiimura Y,et al.Bone mineral loss in patient with chronic obstructive pulmonary disease.Nihon Kyobu Shikkan Gakkai Zasshi,1993,31(12):1548. 被引量：1
8Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large population -based survey. Am J Respir Crit Care Med,2007 ,176 :753-760. 被引量：1
9The American Thoracic Society/European Respiratory Society ( ATS/ ERS). Standards for the diagnosis and management of patients with COPD. Eur Respir J,2004,23:932-946. 被引量：1
10Bauer TI', Monton C, Torres A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndronme, severe pneumonia, and controls. Thorax,2000,55:46-52. 被引量：1
